Greenridge Exploration Inc. ("Greenridge" or the "Company") (CSE: GXP | OTC: GXPLF | FRA: HW3) is pleased to announce the ...

In a future perhaps not too far away, artificial intelligence and its subfield of machine learning (ML) tools and models, ...

"I think there's a small but real chance he's eventually remembered as a Bernie Madoff- or Sam Bankman-Fried-level scammer." ...

Sam Altman, OpenAI’s CEO and the face behind ChatGPT, has built a strong reputation as one of the most influential voices in artificial intelligence. Over time, he has positioned himself as a key AI ...

Artificial intelligence is already proving it can accelerate drug development and improve our understanding of disease. But ...

Methane is one of the most powerful greenhouse gases, yet quantifying its emissions remains difficult at large scales. A new framework, CH4Vision, addresses this problem by estimating methane flux ...

These companies are actually upskilling their workers for AI - here's how they do it ...

Drug Discovery Software Market OverviewThe global drug discovery software market is emerging as a high-impact segment within the life sciences technology ecosystem, driven by the urgent need for ...

Large-scale flow cytometry delivers critical biological insight by enabling multidimensional analysis of individual cells, making it fundamental to medical research. As assays evolve to capture more ...

Nimbus Therapeutics, LLC ("Nimbus Therapeutics" or "Nimbus"), a drug discovery company developing breakthrough medicines through AI-enhanced computational chemistry, today announced that it is ...

Greenridge Exploration Inc. ("Greenridge" or the "Company") (CSE: GXP | OTC: GXPLF | FRA: HW3) is pleased to announce the ...

Platforms run the tactics. Your value now comes from data strategy, business alignment, and owning performance beyond the ad ...